Published in Nucleic Acids Res on February 25, 1986
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J (1989) 10.84
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63
The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J (1991) 2.83
Modified model for the switch from Sendai virus transcription to replication. J Virol (1989) 2.32
The Sendai virus nucleocapsid exists in at least four different helical states. J Virol (1989) 2.30
The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1998) 1.99
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase. J Virol (1993) 1.73
Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.69
Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin. J Virol (1991) 1.65
Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region. Virus Res (2008) 1.63
Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59
The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. J Virol (1998) 1.52
Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol (1988) 1.49
Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro. J Virol (1990) 1.46
Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses. Virus Res (2009) 1.36
Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein. J Virol (1991) 1.35
Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34
The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J Virol (1989) 1.32
Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome. PLoS One (2010) 1.31
Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78. Virus Res (2009) 1.30
Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication. J Virol (1988) 1.24
Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo. J Virol (1989) 1.22
Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses. Virus Res (2009) 1.20
Characterization of in vitro transcription and transcriptional products of measles virus. J Virol (1987) 1.14
Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J Virol (1990) 1.14
Characterizations of the human parainfluenza type 2 virus gene encoding the L protein and the intergenic sequences. Nucleic Acids Res (1991) 1.10
"Rule of six": how does the Sendai virus RNA polymerase keep count? J Virol (2001) 1.08
Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines. J Virol (1994) 1.02
Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J Virol (1991) 1.02
Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins. Nucleic Acids Res (1987) 1.01
Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus. J Virol (1989) 0.98
Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J Virol (1996) 0.98
Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther (2012) 0.97
Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus. J Virol (1994) 0.96
Nucleotide sequence analysis of the L gene of Newcastle disease virus: homologies with Sendai and vesicular stomatitis viruses. Nucleic Acids Res (1987) 0.95
Biology of parainfluenza viruses. Clin Microbiol Rev (1994) 0.95
Given the opportunity, the Sendai virus RNA-dependent RNA polymerase could as well enter its template internally. J Virol (2002) 0.90
Sequence of 2,617 nucleotides from the 3' end of Newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein. Nucleic Acids Res (1986) 0.89
RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. J Cardiovasc Transl Res (2013) 0.84
Cloning and sequencing of the HN gene of Sendai virus (strain Fushimi). Nucleic Acids Res (1990) 0.79
Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I. MBio (2015) 0.78
Rapid accumulation of measles virus leader RNA in the nucleus of infected HeLa cells and human lymphoid cells. J Virol (1991) 0.78
Membrane glycoproteins of Newcastle disease virus: nucleotide sequence of the hemagglutinin-neuraminidase cloned gene and structure/function relationship of predicted amino acid sequence. Glycoconj J (2001) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
New M13 vectors for cloning. Methods Enzymol (1983) 90.74
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A (1979) 72.18
Improved estimation of secondary structure in ribonucleic acids. Nat New Biol (1973) 46.33
Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol (1978) 29.77
High-efficiency cloning of full-length cDNA. Mol Cell Biol (1982) 22.81
Plasmids of Escherichia coli as cloning vectors. Methods Enzymol (1979) 11.41
Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. Nucleic Acids Res (1984) 8.36
Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. Nature (1984) 7.54
Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32
Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature (1980) 4.90
Sendai virus contains overlapping genes expressed from a single mRNA. Cell (1983) 4.71
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations. J Virol (1984) 3.54
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50
N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell (1983) 3.46
Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1984) 3.42
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Classification and nomenclature of viruses. Fourth report of the International Committee on Taxonomy of Viruses. Intervirology (1982) 3.26
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
NH2-terminal hydrophobic region of influenza virus neuraminidase provides the signal function in translocation. Proc Natl Acad Sci U S A (1984) 2.50
Molecular weight determination of Sendai and Newcastle disease virus RNA. J Virol (1974) 2.45
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Regulation of Sendai virus transcription: evidence for a single promoter in vivo. J Virol (1977) 2.02
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Cell (1985) 2.01
Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol (1985) 1.87
Molecular cloning of the 3'-proximal third of Sendai virus genome. Proc Natl Acad Sci U S A (1983) 1.73
Sequence determination of the Sendai virus fusion protein gene. J Gen Virol (1985) 1.73
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
Characterization of bovine parainfluenza virus type 3. Microbiol Immunol (1979) 1.68
Sequences of vesicular stomatitis virus RNA in the region coding for leader RNA, N protein mRNA, and their junction. Proc Natl Acad Sci U S A (1979) 1.48
Analysis of the Sendai virus M gene and protein. J Virol (1984) 1.46
Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30
Preparation and analysis of the nucleocapsid proteins of vesicular stomatitis virus and sendai virus, and analysis of the sendai virus leader-NP gene region. J Gen Virol (1984) 1.20
Molecular cloning of a full-length cDNA encoding the hemagglutinin-neuraminidase glycoprotein of Sendai virus. FEBS Lett (1985) 1.18
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Nucleotide sequence of human rotavirus genome segment 10, an RNA encoding a glycosylated virus protein. J Virol (1984) 1.16
Complete sequence of the Sendai virus NP gene from a cloned insert. Virology (1984) 1.15
Comparison of the nucleotide sequences at the 3'-terminal region of RNAs from RNA coliphages. J Mol Biol (1982) 1.07
Effect of tunicamycin on the replication of Sendai virus. Virology (1982) 1.03
Carbohydrate composition of the envelope glycoproteins of Sendai virus. Virology (1978) 0.87
A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc (1987) 8.45
Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V(1). J Am Coll Cardiol (2001) 4.81
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41
N-linked oligosaccharides are not involved in the function of a cell-cell binding glycoprotein E-cadherin. Cell Struct Funct (1986) 2.90
Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol (1991) 2.87
Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48
Translation of the genetic message. VII. Role of initiation factors in formation of the chain initiation complex with Escherichia coli ribosomes. Arch Biochem Biophys (1968) 2.46
RNA packaging signal of human immunodeficiency virus type 1. Virology (1992) 2.38
Three-step method for ultrasound-guided central vein catheterization. Br J Anaesth (2012) 2.35
Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology (1990) 2.24
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev Biol (2000) 1.80
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem (2000) 1.70
Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci U S A (1997) 1.68
Characterization of bovine parainfluenza virus type 3. Microbiol Immunol (1979) 1.68
Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells (1998) 1.62
Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol (1997) 1.58
Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (1996) 1.56
Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev (2001) 1.53
Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J Virol (1989) 1.50
Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol (1998) 1.50
Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology (1998) 1.47
Adhesion of single application bonding systems to bovine enamel and dentin. Oper Dent (2002) 1.47
Chordoid meningioma in a child. Case report. J Neurosurg (1998) 1.43
Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay. Clin Pharmacol Ther (2009) 1.42
Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer (1986) 1.38
A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J Virol (1994) 1.38
Translation of the genetic message. VI. The role of ribosomal subunits in binding of formylmethionyl-tRNA and its reaction with puromycin. Proc Natl Acad Sci U S A (1967) 1.36
Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus. J Gen Virol (1997) 1.35
Purification and properties of initiation factor F3. Nature (1970) 1.35
Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34
Sendai virus C protein physically associates with Stat1. Genes Cells (2001) 1.29
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Treatment of congenital dislocation of the hip by the Pavlik harness. Mechanism of reduction and usage. J Bone Joint Surg Am (1983) 1.24
The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J Biol Chem (2000) 1.23
Rescue of Sendai virus from viral ribonucleoprotein-transfected cells by infection with recombinant vaccinia viruses carrying Sendai virus L and P/C genes. Virology (1989) 1.23
Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother (1990) 1.23
Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J Gen Virol (1994) 1.22
Polyadenylate in the virion RNA of mouse hepatitis virus. J Biochem (1977) 1.21
V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.17
Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J Biol Chem (1996) 1.17
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS (1996) 1.16
Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions. J Virol (2001) 1.16
Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am J Clin Nutr (1989) 1.15
Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data. J Interferon Cytokine Res (2000) 1.15
Initiation of protein synthesis in Escherichia coli. II. Role of the initiation factors in polypeptide synthesis. Cold Spring Harb Symp Quant Biol (1969) 1.14
Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.14
Transplacental transmission of BK virus in human. Jpn J Microbiol (1975) 1.12
Occupational lifting is associated with hip osteoarthritis: a Japanese case-control study. J Rheumatol (2000) 1.12
Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus. Infect Immun (1983) 1.12
Neuroradiological characteristics of ecchordosis physaliphora. Case report and review of the literature. J Neurosurg (1998) 1.11
Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci (1997) 1.09
HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS. AIDS Res Hum Retroviruses (1997) 1.09
Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett (1999) 1.09
Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity. J Virol (1998) 1.09
Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J Virol (1996) 1.08
Non-invasive visualization of sperm mitochondria behavior in transgenic mice with introduced green fluorescent protein (GFP). FEBS Lett (2001) 1.08
Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Exp Cell Res (1994) 1.07
ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene (2007) 1.06
Plaque formation by sendai virus of parainfluenza virus group, type 1 on monkey, calf kidney and chick embryo cell monolayers. Jpn J Microbiol (1971) 1.05
Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. J Gen Virol (1987) 1.05
Association of the Sendai virus C protein with nucleocapsids. Arch Virol (1990) 1.05
Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene. J Virol (1999) 1.05
Choroid plexus papilloma in the posterior third ventricle: case report. Neurosurgery (1997) 1.04
Syncytium formation of human and non-human cells by recombinant vaccinia viruses carrying the HIV env gene and human CD4 gene. AIDS (1991) 1.04
An improved plaque assay for varicella virus. Arch Virol (1976) 1.04
Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III. J Virol (1999) 1.02
Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins. Nucleic Acids Res (1987) 1.01
Poor correlation between functional results and radiographic findings in Colles' fracture. J Hand Surg Br (1993) 1.01
Sendai virus-based expression of HIV-1 gp120: reinforcement by the V(-) version. Genes Cells (1997) 1.01
Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteins. Virology (1988) 1.01
Combined hyperactive dysfunction syndrome of the cranial nerves: trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia: 11-year experience and review. Neurosurgery (1998) 1.00
CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis. Oncogene (2006) 0.99
IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication. J Leukoc Biol (1998) 0.99
Polypeptide chain elongation factors from pig liver. Methods Enzymol (1979) 0.98
Cross-linking of elongation factor 2 to rat-liver ribosomal proteins by 2-iminothiolane. Eur J Biochem (1986) 0.98
Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. AIDS Res Hum Retroviruses (1994) 0.97
Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells. Microbiol Immunol (1979) 0.96
The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects. Drug Metab Dispos (1999) 0.96
Ulnar wrist pain after Colles' fracture. 109 fractures followed for 4 years. Acta Orthop Scand (1993) 0.95
Gustatory effectiveness of amino acids in mice: behavioral and neurophysiological studies. Physiol Behav (1985) 0.95
Experimental parainfluenzavirus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus. Infect Immun (1982) 0.94
Details of the arrangement of the outer capsid of rice dwarf phytoreovirus, as visualized by two-dimensional crystallography. J Virol (1997) 0.94
Purification and properties of polypeptide chain elongation factor-1alpha from pig liver. J Biochem (1977) 0.94
Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res (1995) 0.94
Experimental parainfluenzavirus infection. 1. Hydrocephalus of mice due to infection with parainfluenza virus type 1 and type 3. Microbiol Immunol (1978) 0.93